Tandem Diabetes Care

Tandem Diabetes Care

Yahoo Finance • 8 days ago

Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?

Tandem Diabetes Care, Inc. TNDM shares rallied 7.7% in the last trading session to close at $17.53. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the... Full story

Yahoo Finance • 16 days ago

Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now

Tandem Diabetes Care, Inc. TNDM is well-positioned to grow in the coming quarters driven by the expanding product choices. The company's pay-as-you-go reimbursement model could lower upfront barriers for pump starts and support higher supp... Full story

Yahoo Finance • 25 days ago

Aging Population Drives Healthcare Growth: Stocks to Watch

An updated edition of the July 6, 2026, article. The world's population is aging rapidly, reshaping how healthcare systems, corporations and investors approach long-term growth opportunities. According to the July 2026 data from the World... Full story

Yahoo Finance • 29 days ago

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' Libre Duo 10 Day Continuous Dual Glucose Ketone Moni... Full story

Yahoo Finance • last month

3 Reasons TNDM is Risky and 1 Stock to Buy Instead

3 Reasons TNDM is Risky and 1 Stock to Buy Instead Over the last six months, Tandem Diabetes's shares have sunk to $22.45, producing a disappointing 13.7% loss - a stark contrast to the S&P 500's 10.5% gain. This might have investors cont... Full story

Yahoo Finance • last month

Nvidia initiated, Teradyne downgraded: Wall Street's top analyst calls

Nvidia initiated, Teradyne downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compile... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes Care (TNDM) Slid as Lower Beta Profile Lags in Risk On Market

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for "Meridian Small Cap Growth Fund". A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fu... Full story

Yahoo Finance • 2 months ago

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as... Full story

Yahoo Finance • 2 months ago

3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and o... Full story

Yahoo Finance • 2 months ago

Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM?

In July 2026, Tandem Diabetes Care announced that its t:slim X2 insulin pump with Control-IQ+ technology is now compatible with Abbott's FreeStyle Libre 3 Plus CGM in the UK, Switzerland, Sweden, Finland, and Italy, expanding CGM choice fo... Full story

Yahoo Finance • 3 months ago

Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Tandem Diabetes Care (TNDM) is back in focus after announcing that its t:slim X2 insulin pump with Control-IQ+ technol... Full story

Yahoo Finance • 3 months ago

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets

Compatibility now available in five countries, with additional markets expected throughout 2026. SAN DIEGO, July 01, 2026--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology comp... Full story

Yahoo Finance • 3 months ago

1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky

1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky The stocks featured in this article are seeing some big returns. Over the past month, they've outpaced the market due to some combination of positive news, upbeat results,... Full story

Yahoo Finance • 4 months ago

Tandem Diabetes rises on Wells Fargo upgrade

[Wall street] * Tandem Diabetes Care (TNDM [https://seekingalpha.com/symbol/TNDM]) is up ~14% in Monday afternoon trading after Wells Fargo upgraded the insulin pump manufacturer to overweight from equal-weight, citing the company's pay... Full story

Yahoo Finance • 4 months ago

What to Know About This $18 Million Bet on a Rental Business With 35 Years of Dividend Growth

Paradice Investment Management disclosed a new position in McGrath RentCorp(NASDAQ:MGRC) on May 14, 2026, with an estimated $17.64 million trade based on quarterly average pricing. What happened Paradice Investment Management initiated a... Full story

Yahoo Finance • 4 months ago

1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about com... Full story

Yahoo Finance • 4 months ago

3 Healthcare Stocks We’re Skeptical Of

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag... Full story

Yahoo Finance • 4 months ago

Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Lowe's(LOW) to Buy from... Full story

Yahoo Finance • 5 months ago

Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Insulin Delivery System Market size & share revenue was valued at approxima... Full story

Yahoo Finance • 6 months ago

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story